General ENT News

ENT

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Holsinger FC et al. - In a study to determine the long-term outcomes of pts with squamous cell carcinoma of the larynx and pharynx who were treated with platin-based exclusive chemotherapy (EC) after they achieved a complete clinical response (CCR) to induction chemotherapy, it was reported that for selected pts, EC may provide long-term, durable disease control. For pts who developed recurrent disease after EC, this approach did not diminish survival and maintained function in the majority of pts.

Methods

Results

Today in Clinical Pharmacology...keeping you current

High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results
Acta Oto-Laryngologica , 12/03/09

Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer
The Laryngoscope, 12/02/09

Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer
European Archives of Oto-Rhino-Laryngology, 12/02/09

Today in Larynx/Trachea/Airway...keeping you current

Ergonomic analysis of microlaryngoscopy
The Laryngoscope, 12/03/09

Impact of age at diagnosis on prognosis and treatment in laryngeal cancer
Head & Neck, 12/03/09

Complications and functional outcomes following complex oropharyngeal reconstruction
Head & Neck, 12/03/09